
PARP-1 Inhibitors and Their Emerging Role in the Treatment of Lung Cancer
Published: | Updated:
Lung cancer is one of the leading causes of death worldwide. The standard of care for advanced small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) includes platinumbased chemotherapy.
